Evidence map›Paper›PMID 30770470›Full record

ArticleThe Journal of biological chemistry2019

HDAC6 regulates DNA damage response via deacetylating MLH1.

Mu Zhang, Chen Hu, Niko Moses, Joshua Haakenson, Shengyan Xiang, Daniel Quan, Bin Fang, Zhe Yang, Wenlong Bai, Gerold Bepler and 2 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Article
  3. The role and mechanism of histone deacetylase in COPD.Molecular and cellular biochemistry · 2026
    Review
  4. Curcumin in High Doses Reverses the UV-B-InducedPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Role of HDAC6 in carcinomas.Discover oncology · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. HDAC6: A unique HDAC family member as a cancer target.Cellular oncology (Dordrecht, Netherlands) · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mu ZhangFrom the Karmanos Cancer Institute, Molecular Therapeutics Program, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201.
Chen HuFrom the Karmanos Cancer Institute, Molecular Therapeutics Program, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201.
Niko Mosesthe Karmanos Cancer Institute, Cancer Biology Graduate Program, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201.
Joshua Haakensonthe Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612.
Shengyan Xiangthe Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612.
Daniel Quanthe Wayne State University School of Medicine, Detroit, Michigan 48201.
Bin Fangthe The Proteomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612.
Zhe YangDepartment of Microbiology, Immunology and Biochemistry, Wayne State University School of Medicine, Detroit, Michigan 48201.
Wenlong Baithe Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612.
Gerold BeplerFrom the Karmanos Cancer Institute, Molecular Therapeutics Program, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201.
Guo-Min Lithe Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75390.
Xiaohong Mary ZhangFrom the Karmanos Cancer Institute, Molecular Therapeutics Program, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201. Electronic address: zhangx@karmanos.org.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
TRAINING PROGRAM IN THE BIOLOGY OF CANCERT32CA009531 · NCI · WAYNE STATE UNIVERSITY · PI Larry H Matherly · 1985 to 2026
$5.3M
ROLE OF HDAC6 IN PLATINUM RESISTANCE OF NON-SMALL CELL LUNG CANCERR01CA164147 · NCI · WAYNE STATE UNIVERSITY · PI ZHANG, XIAOHONG MARY · 2012 to 2016
$1.6M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA164147
6 · The paper itself

Abstract

MutL homolog 1 (MLH1) is a key DNA mismatch repair protein, which plays an important role in maintenance of genomic stability and the DNA damage response. Here, we report that MLH1 is a novel substrate of histone deacetylase 6 (HDAC6). HDAC6 interacts with and deacetylates MLH1 both

Indexed as

DNA DamageAcetylationCell LineHistone Deacetylase 6HumansMutationMutL Protein Homolog 1MutL ProteinsMutS DNA Mismatch-Binding ProteinThioguanineHDAC6 protein, humanHistone Deacetylase 6MLH1 protein, humanMutLalpha protein, humanMutL Protein Homolog 1MutL ProteinsMutS DNA Mismatch-Binding ProteinThioguanineacetylationDNA damage responseDNA mismatch repairDNA repairdrug resistanceHDAC6histone deacetylase 6 (HDAC6)MLH1

Identifiers

PMID30770470
PMCPMC6463726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.